We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for osilodrostat (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
osilodrostat
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of endogenous Cushing's syndrome in adults
Therapeutic area
Endocrinology